Voyager taps new business chief amid 'significant interest' from partners; Oncopeptides faces another CEO, CFO reset
Beth Shafer was taught to leave a place better than she found it. As Voyager Therapeutics’ new chief business officer, that’s exactly what she intends …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
